Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 20, 2018 ) Summary
This report provides an overview of the fungal foot infection pipeline landscape. It provides comprehensive information on the therapeutics under development for onychomycosis (Tinea unguium) and athlete’s foot (Tinea pedis), and key players active within these indications.
Both of these indications are fungal infections primarily affecting the feet. Onychomycosis affects the nails, whereas athlete’s foot affects the skin under the feet and between the toes. Common symptoms include discomfort, itchiness, and - in the case of onychomycosis - discoloured and disfigured nails. Combined, these infections affect around 25% of the adult population.
There is considerable overlap in both the development of pipeline products and existing marketed products between the two indications, which reflects similarities in the underlying pathophysiology. There are a total of 25 products in development for both indications, by 24 companies.
Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2117413 .
Scope
- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2117413 .
Companies Mentioned:
Almirall SA Astellas Pharma Inc Biolab Farmaceutica Ltda Blueberry Therapeutics Ltd Broda Tech LLC Dermala Inc Eisai Co Ltd Helix BioMedix Inc Hexima Ltd Kaken Pharmaceutical Co Ltd Meiji Seika Pharma Co Ltd Moberg Pharma AB NAL Pharmaceuticals Ltd Novabiotics Ltd Novan Inc Novoteris LLC Onychomycosis (Tinea Unguium) Sanotize Research And Development Corp Tinea pedis (Athlete Foot) Viamet Pharmaceuticals Inc Browse the complete report @ http://orbisresearch.com/reports/index/fungal-foot-infections-drug-development-pipeline-review-2018 .
Table of Content:
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Fungal Foot Infections Report Coverage 7
2.2 Onychomycosis (Tinea Unguium) - Overview 7
2.3 Tinea pedis (Athlete Foot) - Overview 7
3 Therapeutics Development 8
3.1 Onychomycosis (Tinea Unguium) 8
3.2 Tinea pedis (Athlete Foot) 12
4 Therapeutics Assessment 15
4.1 Onychomycosis (Tinea Unguium) 15
4.2 Tinea pedis (Athlete Foot) 21
Make an Enquiry of this report @ http://orbisresearch.com/contacts/enquiry-before-buying/2117413 .
5 Companies Involved in Therapeutics Development 26
5.1 Onychomycosis (Tinea Unguium) 26
5.2 Tinea pedis (Athlete Foot) 32
6 Dormant Projects 36
6.1 Onychomycosis (Tinea Unguium) 36
6.2 Tinea pedis (Athlete Foot) 38
7 Discontinued Products 39
7.1 Onychomycosis (Tinea Unguium) 39
8 Product Development Milestones 40
8.1 Onychomycosis (Tinea Unguium) 40
8.2 Tinea pedis (Athlete Foot) 50
9 Appendix 57
9.1 Methodology 57
9.2 Coverage 57
9.3 Secondary Research 57
9.4 Primary Research 57
9.5 Expert Panel Validation 57
9.6 Contact Us 58
9.7 Disclaimer 58
Contact sales@orbisresearch.com for more information.
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Orbis Research
Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|